Abstract Background Anastomotic leak (AL) is a serious complication following oesophagectomy that occurs in 10-15% of patients. Endoscopic vacuum therapy (EVT) is a novel non-operative approach to managing AL that has become increasingly popular recently. However, little is known about EVT’s effectiveness in managing ALs compared to more established approaches. Method This was a retrospective review of consecutive AL management in a regional oesophageal cancer centre during two distinct time periods: prior to (group 1, 2014-2018) and following (group 2, 2018-2023) the introduction of EVT. 66 patients met the inclusion criteria. Patients were further classified according to size and type of leak, degree of mediastinal soiling and degree of sepsis. Primary endpoints were treatment success, 90-day mortality, and long-term preservation of gastrointestinal continuity. Secondary endpoints were the length of hospital stay (LOS) and re-interventions during the first postoperative year. Results 80.3% of patients (14 in group 1, 40 in group 2) had less than 1cm AL defect with present sepsis and a small mediastinal cavity. In group 1, 12 were treated successfully conservatively, and 2 (14.2%) had T-tube insertion. In group 2, 20 (50%) had conservative management and 19 (47.5%) had Esosponge insertion. The success rate was 95% and 94.7%, respectively. In bigger ALs (>1cm defect with severe sepsis), all patients in group I were treated with thoracotomy with a success rate of 75%, whereas in group 2, 60% were treated with Esosponge insertion with a success rate of 83.3%. Conclusion EVT is a safe and feasible therapy option. It appears to improve outcomes in septic patients with small ALs and potentially reduces the need for high-risk revisional operations.
Read full abstract